The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

AEterna Zentaris Inc

Nasdaq: AEZS
Last

(U.S.) $0.09

Today's change+0.00 +1.03%
Updated September 3 1:34 PM -4GMT. Delayed by at least 15 minutes.
 

AEterna Zentaris Inc

Nasdaq: AEZS
Last

(U.S.) $0.09

Today's change+0.00 +1.03%
Updated September 3 1:34 PM -4GMT. Delayed by at least 15 minutes.

AEterna Zentaris Inc up (U.S.)$0.00

AEterna Zentaris Inc is up today by (U.S.)$0.00 or 1.03% to (U.S.)$0.09. Over the last five days, shares have gained 3.74%, but are down 85.22% for the last year to date. Shares have underperformed the S&P 500 by 91.58% during the last year.

Key company metrics

  • Open(U.S.) $0.09
  • Previous close(U.S.) $0.09
  • High(U.S.) $0.09
  • Low(U.S.) $0.09
  • Bid / Ask(U.S.) $0.09 / (U.S.) $0.09
  • YTD % change-85.22%
  • Volume14,621,691
  • Average volume (10-day)11,904,194
  • Average volume (1-month)12,211,169
  • Average volume (3-month)7,016,304
  • 52-week range(U.S.) $0.08 to (U.S.) $1.46
  • Beta2.44
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.41
Updated September 3 1:34 PM -4GMT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-11,536.66%

AEterna Zentaris Inc has a net profit margin of -11,536.66%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.37%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit----00
Total cost of revenue----00
Total operating expense8101110
Selling / general / administrative4554
Research & development4466
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-8-10-11-10
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-15-104-12
Income after tax-15-104-12
Income tax, total--000
Net income-15-104-11
Total adjustments to net income--------
Net income before extra. items-15-104-12
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-15-104-12
Inc. avail. to common incl. extra. items-15-104-11
Diluted net income-15-104-11
Dilution adjustment--000
Diluted weighted average shares111726559
Diluted EPS excluding extraordinary itemsvalue per share-0.14-0.130.06-0.20
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.14-0.130.06-0.20